
AI in MedTech: We need to strike the right balance between innovation and regulation
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Back to Top
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Diane Bullman reveals the difference mentoring made to this year’s participants and looks ahead to the 2025 programme – which includes a new stream run
Clinicians need a culture of education and understanding to get the best out of AI and protect themselves and their patients from inappropriate information, writes
As a service, pharmacy dislikes change, preferring to apply ‘band-aids’ to traditional systems. But the advantages of digitising are now too great to ignore, writes
Digital Health’s Advisory Panel invited members of the Shuri Network to join the panel last year. For Vicki Kong and Elohor Uwadiogbu it was a
Artificial intelligence has huge potential in pathology. But to realise its benefits, suppliers should work
A new £21 million investment in AI aims to modernise NHS diagnostics and improve wait
The FCI is said to be falling apart with the Chair of Trustees and CEO
Digital solutions can improve information sharing and reduce the errors that cost lives. But they
Tech companies who have invested heavily in the healthcare market could do much more to